Momenta, Sandoz Try To Pause Blood-Clot Drug Antitrust Suit
Momenta and Sandoz have urged a Tennessee federal judge to pause a lawsuit accusing them of conspiring to monopolize blood-clot drug Lovenox and its generic version while they appeal the certification...To view the full article, register now.
Already a subscriber? Click here to view full article